Reproduced from CivicScience; Chart: Axios Visuals

Reactions to the coronavirus pandemic and "stay at home" orders have varied greatly across the U.S., but new data from CivicScience shows that a plurality of Americans are leaving their homes just once a week.

Between the lines: "Those who have been diagnosed with COVID-19 or know someone who has been are more likely to cap their trips out at 1-2 times per week," CivicScience analysts note. "The fact that those further removed from the virus are going out upwards of three to four times a week suggests that for many, it takes a personal connection for some to change their behavior."

Go deeper

Caitlin Owens, author of Vitals
Jul 29, 2020 - Health

Reopening schools is a lose-lose dilemma for many families of color

Reproduced from KFF Health Tracking Poll; Note: Share includes responses for "very/somewhat worried", income is household income; Chart: Axios Visuals

Children of color have the most to lose if schools remain physically closed in the fall. Their families also have the most to lose if schools reopen.

Why it matters: The child care crisis created by the coronavirus pandemic is horrible for parents regardless of their race or income, but Black and Latino communities are bearing the heaviest burden.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: Biden ahead in Wisconsin, Michigan as cases surge in the Midwest.
  2. Health: Surge "is real" and not just caused by more tests, Trump's testing czar saysMask mandates help control the rise in hospitalizations Some coronavirus survivors have "autoantibodies."
  3. Business: Surge is sinking consumer confidence Testing is a windfall.
  4. Media: Pandemic causes TV providers to lose the most subscribers ever.
  5. World: Putin mandates face masks.
Jul 29, 2020 - Health

Moderna vaccine protects against coronavirus in monkeys

Scientist Xinhua Yan works in the lab at Moderna in Cambridge, Mass. Photo: David L. Ryan/The Boston Globe via Getty Images

Moderna's experimental COVID-19 vaccine has induced a "robust" immune response and protection from the virus in the noses and lungs of monkeys, according to a study published in the New England Journal of Medicine Tuesday.

Why it matters: The National Institutes for Health, which co-developed the vaccine, noted in a statement Tuesday, "This is the first time an experimental COVID-19 vaccine tested in nonhuman primates has been shown to produce such rapid viral control in the upper airway."